BNP Paribas Financial Markets’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$993K Buy
878,987
+7,390
+0.8% +$8.35K ﹤0.01% 2207
2025
Q1
$1.27M Buy
871,597
+21,939
+3% +$32K ﹤0.01% 1891
2024
Q4
$1.81M Buy
849,658
+803,284
+1,732% +$1.71M ﹤0.01% 1729
2024
Q3
$130K Buy
46,374
+39,145
+541% +$110K ﹤0.01% 2673
2024
Q2
$16.8K Sell
7,229
-52,591
-88% -$123K ﹤0.01% 2978
2024
Q1
$267K Sell
59,820
-63,698
-52% -$285K ﹤0.01% 2494
2023
Q4
$396K Sell
123,518
-446,437
-78% -$1.43M ﹤0.01% 2241
2023
Q3
$1.81M Buy
569,955
+332,660
+140% +$1.05M ﹤0.01% 1412
2023
Q2
$1.18M Sell
237,295
-27,340
-10% -$136K ﹤0.01% 1558
2023
Q1
$1.31M Buy
264,635
+17,847
+7% +$88.2K ﹤0.01% 1608
2022
Q4
$1.55M Sell
246,788
-41,602
-14% -$262K ﹤0.01% 1363
2022
Q3
$3.11M Buy
288,390
+256,934
+817% +$2.77M 0.01% 1166
2022
Q2
$359K Buy
31,456
+22,315
+244% +$254K ﹤0.01% 2218
2022
Q1
$83.3K Sell
9,141
-11,258
-55% -$103K ﹤0.01% 2847
2021
Q4
$304K Buy
20,399
+4,958
+32% +$74K ﹤0.01% 2613
2021
Q3
$397K Buy
15,441
+12,805
+486% +$329K ﹤0.01% 2260
2021
Q2
$68.7K Sell
2,636
-4,313
-62% -$112K ﹤0.01% 2560
2021
Q1
$245K Buy
6,949
+1,226
+21% +$43.3K ﹤0.01% 2397
2020
Q4
$144K Sell
5,723
-6,949
-55% -$175K ﹤0.01% 2395
2020
Q3
$478K Sell
12,672
-8,099
-39% -$305K ﹤0.01% 1667
2020
Q2
$889K Sell
20,771
-915
-4% -$39.2K ﹤0.01% 1338
2020
Q1
$422K Buy
21,686
+16,112
+289% +$313K ﹤0.01% 1884
2019
Q4
$145K Sell
5,574
-1,111
-17% -$28.9K ﹤0.01% 2459
2019
Q3
$182K Buy
6,685
+3,244
+94% +$88.4K ﹤0.01% 2187
2019
Q2
$92.4K Buy
+3,441
New +$92.4K ﹤0.01% 2472